HomeOrganizations › THE FAMILIAL HYPERCHOLESTEROLEMIA FOUNDATION

THE FAMILIAL HYPERCHOLESTEROLEMIA FOUNDATION

FL · Disease Research · EIN 454597425

15
Executives Disclosed
$8.9M
Annual Revenue
$7.4M
Total Assets
1.8:1
Internal Pay Ratio

THE FAMILIAL HYPERCHOLESTEROLEMIA FOUNDATION has 15 executives with disclosed compensation. The highest-paid executive, Katherine Wilemon (CEO/Board Member), received peak total compensation of $452,099. The sector average for Disease Research executives is $215K.


Top Executive Compensation Over Time


Executive Compensation

Name Title Peak Comp. Latest Comp. Years vs. Household
Katherine Wilemon CEO/Board Member $452K $403K 2016–2024 6x
Hilliard Paige Chief Innovation Officer $402K $402K 2023–2024 5.4x
Allison Hawke VP of Operations $234K $234K 2024–2024 3.1x
M McGowan CMO $231K $231K 2020–2023 3.1x
Diane MacDougall VP of Science and Research $220K $220K 2023–2024 2.9x
Catherine Ahmed VP of Policy $180K $0 2017–2023 2.4x
A Sheldon VP of Marketing $179K $179K 2019–2020 2.4x
Amanda Sheldon VP, Marketing & Communications $173K $173K 2018–2018 2.3x
S Gidding CMedO (Term end Dec.) $153K $153K 2019–2019 2x
Susan Seim Creative Director $150K $0 2023–2024 2x
Barbara Gladders Sr. Healthcare Data Analyst $143K $0 2024–2024 1.9x
E Erikson Finance Manager (end Nov) $131K $0 2020–2022 1.8x
Carole King Dir. of Development $125K $0 2016–2016 1.7x
E Fennell Development Director $116K $0 2019–2019 1.6x
Stacey Stanley Executive Assistant $113K $0 2017–2017 1.5x

Annual Summary

Year Executives Avg. Comp. Highest Comp. Total Payroll
2016 2 $266K $266K $266K
2017 3 $311K $311K $311K
2018 3 $247K $321K $493K
2019 5 $206K $338K $824K
2020 5 $222K $308K $665K
2021 4 $260K $340K $520K
2022 4 $251K $408K $752K
2023 6 $305K $452K $1.2M
2024 6 $315K $403K $1.3M
Email Alerts

Get notified about THE FAMILIAL HYPERCHOLESTEROLEMIA FOUNDATION

Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.